Skip to main content
Top
Published in: Virology Journal 1/2017

Open Access 01-12-2017 | Research

Hospital-visiting pregnant women signal an increased spread of hepatitis C infection in Khyber Pakhtunkhwa region of Pakistan

Authors: Zobia Afsheen, Bashir Ahmad, Shumaila Bashir

Published in: Virology Journal | Issue 1/2017

Login to get access

Abstract

Background

Seroprevalence of hepatitis C in Khyber Pakhtunkhwa province of Pakistan was determined by screening blood samples of expectant mothers seeking antenatal care in gynecological units of district hospitals. The rationale behind this cohort study was that the availability of free-of-cost antenatal care in district hospitals brings expectant mothers from a broader geographical range in each district and thus provides a large sample-size of healthy pregnant women of known medical history for Hepatitis C Virus (HCV) surveillance. The study was carried out along a south west to north east transact of five districts, Kohat-Peshawar-Nowshera-Charsadda-Mardan, with the central district Peshawar and outer districts Kohat and Mardan bordering northern mountainous ranges of the Khyber Pakhtunkhwa province. This distribution of districts along the transact allowed the study to gauge the impact of proximity to remote highland communities on the HCV burden of visiting pregnant women tested for HCV infection.

Methods

The cohort study randomly selected 150 pregnant women visiting each hospital for serological screening for Anti-HCV carried out by ELISA assay. The feasibility of ICT and RT-PCR assays for HCV prevalence was also examined in the present study.

Results

With a total of 750 blood specimen screened, the results of ELISA tests revealed a staggering 5.9% frequency of Anti-HCV in the five districts with the frequency of ELISA positive cases ranging from 3.3% in Nowshera, 4.7% in Charsadda, 6.0% in Peshawar, 6.7% in Kohat, and 8.7% in Mardan. The relatively higher frequencies of Anti-HCV cases among hospital visiting pregnant women in Peshawar, Kohat and Mardan were consistent with the proximity of these hospitals to the highland communities in the bordering mountain ranges. Compared to 44 Anti-HCV positive serologic specimens detected by ELISA, only 26 and 10 blood specimens were tested positive by ICT and PCR methods, respectively. Our study validates ELISA as a reliable diagnostic technique for both acute and chronic HCV infection.

Conclusion

The HCV infection rate of 5.9% in Khyber Pakhtunkhwa province clearly exceeds the HCV prevalence rates reported for other regions in Pakistan, making this province a hotspot of HCV infection in the country.
Literature
1.
go back to reference Kang W, Sung PS, Park SH, Yoon S, Chang DY, Kim S, et al. Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions. Gastroenterology. 2014;146(5):1351–60.CrossRefPubMedPubMedCentral Kang W, Sung PS, Park SH, Yoon S, Chang DY, Kim S, et al. Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions. Gastroenterology. 2014;146(5):1351–60.CrossRefPubMedPubMedCentral
2.
go back to reference Marranconi F, Fabris P, Stecca C, Zampieri L, Battini MC, Fabrizio N. Prevalence of anti-HCV and risk factor for hepatitis c virus in- fection in healthy pregnant women. Infection. 1994;22:333–7.CrossRefPubMed Marranconi F, Fabris P, Stecca C, Zampieri L, Battini MC, Fabrizio N. Prevalence of anti-HCV and risk factor for hepatitis c virus in- fection in healthy pregnant women. Infection. 1994;22:333–7.CrossRefPubMed
3.
go back to reference Resti M, Azzari C, Mannelli F, Moriondo M, Novembre E, Martino M, Vierucci A. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. BMJ. 1998;317(7156):437–41.CrossRefPubMedPubMedCentral Resti M, Azzari C, Mannelli F, Moriondo M, Novembre E, Martino M, Vierucci A. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. BMJ. 1998;317(7156):437–41.CrossRefPubMedPubMedCentral
5.
go back to reference Ojule AC, Akani CI, Opurum HC. Seroprevalence of hepatitis C antibodies in pregnant women in Port Harcourt, Nigeria. Port Harcourt Medical Journal. 2008;3(1):55–61.CrossRef Ojule AC, Akani CI, Opurum HC. Seroprevalence of hepatitis C antibodies in pregnant women in Port Harcourt, Nigeria. Port Harcourt Medical Journal. 2008;3(1):55–61.CrossRef
6.
go back to reference Elinav E, IZ B-D, Shapira Y, Daudi N, Adler R, Shouval D, Ackerman Z. Acute hepatitis a infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology. 2006;130(4):1129–34.CrossRefPubMed Elinav E, IZ B-D, Shapira Y, Daudi N, Adler R, Shouval D, Ackerman Z. Acute hepatitis a infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology. 2006;130(4):1129–34.CrossRefPubMed
7.
go back to reference Ornoy A, Tenenbaum A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol. 2006;21(4):446–57.CrossRefPubMed Ornoy A, Tenenbaum A. Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol. 2006;21(4):446–57.CrossRefPubMed
8.
go back to reference Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case–control study. J Hepatol. 2005;43(5):771–5.CrossRefPubMed Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case–control study. J Hepatol. 2005;43(5):771–5.CrossRefPubMed
9.
go back to reference Elsheikh RM, Daak AA, Elsheikh MA, Karsany MS, Adam I. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virol J. 2007;4(1):1.CrossRef Elsheikh RM, Daak AA, Elsheikh MA, Karsany MS, Adam I. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virol J. 2007;4(1):1.CrossRef
11.
go back to reference Nwankiti OO, Ejekwolu AJ, Ndako AJ, Chollom S, Samuel E. A survey for antibodies to hepatitis C virus among women of childbearing age. Nature and Science. 2012;10(9):148–52. Nwankiti OO, Ejekwolu AJ, Ndako AJ, Chollom S, Samuel E. A survey for antibodies to hepatitis C virus among women of childbearing age. Nature and Science. 2012;10(9):148–52.
12.
go back to reference Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61:77–87.CrossRefPubMed Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61:77–87.CrossRefPubMed
13.
go back to reference Lavanchy D. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, Antwerp, Belgium. J Viral Hepat. 1999;6(1):35–47.CrossRef Lavanchy D. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, Antwerp, Belgium. J Viral Hepat. 1999;6(1):35–47.CrossRef
14.
go back to reference Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis. 2002;2(5):293–302.CrossRefPubMed Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis. 2002;2(5):293–302.CrossRefPubMed
15.
go back to reference Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B & C in Pakistan: prevalence and risk factors. Int J Infect Dis. 2009;13(1):9–19.CrossRefPubMed Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B & C in Pakistan: prevalence and risk factors. Int J Infect Dis. 2009;13(1):9–19.CrossRefPubMed
16.
go back to reference Umar M, Bushra H, Ahmad M, Khurram M, Usman S, Arif M, et al. Hepatitis C in Pakistan: a review of available data. Hepat Mon. 2010;10(3):205–14.PubMedPubMedCentral Umar M, Bushra H, Ahmad M, Khurram M, Usman S, Arif M, et al. Hepatitis C in Pakistan: a review of available data. Hepat Mon. 2010;10(3):205–14.PubMedPubMedCentral
17.
go back to reference Anwar MI, Rahman M, Hassan MU, Iqbal M. Prevalence of active hepatitis C virus infections among general public of Lahore, Pakistan. Virol J. 2013;10:351.CrossRefPubMedPubMedCentral Anwar MI, Rahman M, Hassan MU, Iqbal M. Prevalence of active hepatitis C virus infections among general public of Lahore, Pakistan. Virol J. 2013;10:351.CrossRefPubMedPubMedCentral
18.
go back to reference Riaz S, Bashir MF, Haider S, Rahid N. Association of genotypes with viral load and biochemical markers in HCV-infected Sindhi patients. Braz J Microbiol. 2016;47(4):980–6.CrossRefPubMedPubMedCentral Riaz S, Bashir MF, Haider S, Rahid N. Association of genotypes with viral load and biochemical markers in HCV-infected Sindhi patients. Braz J Microbiol. 2016;47(4):980–6.CrossRefPubMedPubMedCentral
19.
go back to reference MMWR. Establishment of a viral hepatitis surveillance system--Pakistan, 2009-2011. MMWR Morb Mortal Wkly Rep. 2011;60:1385–90. MMWR. Establishment of a viral hepatitis surveillance system--Pakistan, 2009-2011. MMWR Morb Mortal Wkly Rep. 2011;60:1385–90.
20.
go back to reference Jiwani N, Gull RB. A silent storm: hepatitis C in Pakistan. Journal of Pioneering Medical Sciences. 2011;1(3):89–91. Jiwani N, Gull RB. A silent storm: hepatitis C in Pakistan. Journal of Pioneering Medical Sciences. 2011;1(3):89–91.
21.
go back to reference Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc. 2002;52:398–402.PubMed Khattak MF, Salamat N, Bhatti FA, Qureshi TZ. Seroprevalence of hepatitis B, C and HIV in blood donors in northern Pakistan. J Pak Med Assoc. 2002;52:398–402.PubMed
22.
go back to reference Waqar M, Khan AU, Ali A, Wasim M, Idrees M, Ismail Z, et al: Prevalence and molecular determination of hepatitis C infection in Khyber Pakhtunkhwa, Pakistan Arch Clin Infect Dis 2014; 9(3): e17275. Waqar M, Khan AU, Ali A, Wasim M, Idrees M, Ismail Z, et al: Prevalence and molecular determination of hepatitis C infection in Khyber Pakhtunkhwa, Pakistan Arch Clin Infect Dis 2014; 9(3): e17275.
23.
go back to reference Kwenti TE, Njouom R, Njunda LA, Kamga HLF. Comparison of an Immunochromatographic rapid strip test, ELISA and PCR in the diagnosis of hepatitis C in HIV patients in hospital settings in Cameroon. Clinical Medicine and Diagnostics. 2011;1(1):21–7.CrossRef Kwenti TE, Njouom R, Njunda LA, Kamga HLF. Comparison of an Immunochromatographic rapid strip test, ELISA and PCR in the diagnosis of hepatitis C in HIV patients in hospital settings in Cameroon. Clinical Medicine and Diagnostics. 2011;1(1):21–7.CrossRef
24.
go back to reference Afdhal N, Zeuzem S, Kwo P, et al. Ledipasvir and Sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med. 2014;370:1889–98.CrossRefPubMed Afdhal N, Zeuzem S, Kwo P, et al. Ledipasvir and Sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med. 2014;370:1889–98.CrossRefPubMed
Metadata
Title
Hospital-visiting pregnant women signal an increased spread of hepatitis C infection in Khyber Pakhtunkhwa region of Pakistan
Authors
Zobia Afsheen
Bashir Ahmad
Shumaila Bashir
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2017
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-017-0861-y

Other articles of this Issue 1/2017

Virology Journal 1/2017 Go to the issue